The PKG™ system provides continuous, objective, ambulatory assessment of movement disorder symptoms, such as tremor, dyskinesia and bradykinesia during activities of daily living and in the patient's home environment.
Consisting of an interactive watch that collects movement data, proprietary algorithms and a detailed report, the PKG™ system also correlates the frequency and severity of symptoms with respect to consumption of Parkinson's medication.
-
11 April 2018Read More
GKC has successfully secured funding from the high profile and leading international funder in Parkinson's - The Michael J. Fox Foundation as well as the Shake It Up Australia Foundation and Parkinson…
-
11 April 2018Read More
The Australian Federal Government’s Biomedical Translation Fund has invested $7.7.million in the commercialization of GKC’s Parkinson’s KinetiGraph™ (PKG™) as the company makes inroads to obtaining re…
-
05 April 2018Read More
Reported in Nature's npj Parkinson's Disease, the study demonstrates the use of objective targets and measurement with the PKG system significantly improved clinical care and quality of life for peopl…